The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.
Cilengitide is a high-affinity cyclic pentapeptdic alphaV integrin antagonist previously Tampers reported to suppress angiogenesis by inducing anoikis of endothelial cells adhering through alphaVbeta3/alphaVbeta5 integrins.Angiogenic endothelial cells express multiple integrins, in particular those of the beta1 family, and little is known on the ef